Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant CD80 (Galiximab Biosimilar) anticorps

Cet anticorps Human Monoclonal détecte spécifiquement CD80 (Galiximab Biosimilar) dans FACS, BR, ELISA, IHC, IP et WB. Il présente une réactivité avec des échantillons de Humain.
N° du produit ABIN7072387
-15% Promotion 2026
530,40 €
624,00 €
Économisez 93,60 € (-15 %)
Plus frais de livraison 40,00 € et TVA
200 μg
Destination: France
Envoi sous 4 à 8 jours ouvrables

Aperçu rapide pour Recombinant CD80 (Galiximab Biosimilar) anticorps (ABIN7072387)

Antigène

CD80 (Galiximab Biosimilar)

Type d'anticorp

Recombinant Antibody

Reactivité

Humain

Hôte

  • 1
  • 1
  • 1
  • 1
Human

Clonalité

  • 2
  • 2
Monoclonal

Conjugué

  • 4
Cet anticorp CD80 (Galiximab Biosimilar) est non-conjugé

Application

  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Blocking Reagent (BR), ELISA, Immunohistochemistry (IHC), Immunoprecipitation (IP), Western Blotting (WB)

Clone

IDEC-114
  • Fonction

    Anti-CD80 [IDEC-114 (Galiximab)], Human IgG1, lambda

    Specificité

    Galiximab is a primatized mAb which consists of human constant and primate (cynomolgus macaque) variable regions and binds specifically to CD80. CD80 is a surface glycoprotein and a member of the B7 family of costimulatory molecules. CD80 antigen regulates T cell activation (through interacting with CD28 or CD152) and is expressed transiently in antigen-presenting cells, T cells and normal B cells, and expressed consitutively on various subtypes of B-cell lymphomas.

    Attributs du produit

    Original Species of Ab: Human

    Original Format of Ab: IgG1

    Purification

    Protein A affinity purified

    Immunogène

    Galiximab was prepared by immunizing cynomolgus monkeys with recombinant CD80 antigen. The variable regions of the light and heavy chains were then cloned by being incorporated into a cassette vector (N5LG1) containing human constant region genes and subsequently transfected into the Dg44 CHO cell line (Hariharan K, 2013)

    Isotype

    IgG1 lambda
  • Indications d'application

    Galiximab acts to decrease in cell proliferation, inhibition of the constitutively active NF-κB pathway, increase in apoptosis and ADCC against various B-cell lymphoma cell lines. Galiximb affects CD28 and CD152 interactions with CD80. This antibody can also be used for FC, WB, ELISA, IP and IHC.

    Restrictions

    For Research Use only
  • Concentration

    1 mg/mL

    Buffer

    PBS with 0.02 % Proclin 300.

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Antigène

    CD80 (Galiximab Biosimilar)

    Classe de substances

    Biosimilar

    Sujet

    B7-1, T-lymphocyte activation antigen CD80, Activation B7-1 antigen, BB1, CTLA-4 counter-receptor B7.1, B7

    UniProt

    P33681
Vous êtes ici:
Chat with us!